Artal Group as of Sept. 30, 2015
Portfolio Holdings for Artal Group
Artal Group holds 63 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blue Buffalo Pet Prods | 46.0 | $2.1B | 115M | 17.91 | |
| Lexicon Pharmaceuticals (LXRX) | 13.8 | $618M | 58M | 10.74 | |
| Weight Watchers International | 4.2 | $188M | 29M | 6.38 | |
| Biogen Idec (BIIB) | 2.6 | $117M | 400k | 291.81 | |
| Wal-Mart Stores (WMT) | 2.4 | $108M | 1.7M | 64.84 | |
| Goldman Sachs (GS) | 1.9 | $87M | 500k | 173.76 | |
| JPMorgan Chase & Co. (JPM) | 1.8 | $79M | 1.3M | 60.97 | |
| Celgene Corporation | 1.6 | $70M | 650k | 108.17 | |
| Bank of America Corporation (BAC) | 1.4 | $62M | 4.0M | 15.58 | |
| MetLife (MET) | 1.3 | $59M | 1.3M | 47.15 | |
| BioMarin Pharmaceutical (BMRN) | 1.3 | $57M | 540k | 105.32 | |
| Incyte Corporation (INCY) | 1.2 | $54M | 490k | 110.33 | |
| General Electric Company | 1.1 | $50M | 2.0M | 25.22 | |
| Alibaba Group Holding (BABA) | 1.1 | $47M | 800k | 58.97 | |
| General Motors Company (GM) | 1.0 | $44M | 1.5M | 30.02 | |
| Morgan Stanley (MS) | 0.9 | $39M | 1.3M | 31.50 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $39M | 485k | 80.36 | |
| Google Inc Class C | 0.8 | $37M | 60k | 608.42 | |
| Endo International (ENDPQ) | 0.8 | $35M | 500k | 69.28 | |
| American Express Company (AXP) | 0.8 | $33M | 450k | 74.13 | |
| Yum! Brands (YUM) | 0.7 | $32M | 400k | 79.95 | |
| Bluebird Bio (BLUE) | 0.7 | $31M | 365k | 85.55 | |
| Kite Pharma | 0.7 | $30M | 540k | 55.68 | |
| Bristol Myers Squibb (BMY) | 0.7 | $30M | 500k | 59.20 | |
| Gilead Sciences (GILD) | 0.7 | $30M | 300k | 98.19 | |
| SPDR S&P Biotech (XBI) | 0.6 | $28M | 450k | 62.25 | |
| Citigroup (C) | 0.6 | $27M | 550k | 49.61 | |
| MasterCard Incorporated (MA) | 0.6 | $27M | 300k | 90.12 | |
| Qualcomm (QCOM) | 0.6 | $27M | 500k | 53.73 | |
| Teva Pharmaceutical Industries (TEVA) | 0.6 | $25M | 450k | 56.46 | |
| Merck & Co (MRK) | 0.6 | $25M | 500k | 49.39 | |
| Linkedin Corp | 0.5 | $24M | 125k | 190.13 | |
| Apple (AAPL) | 0.5 | $22M | 200k | 110.30 | |
| ISIS Pharmaceuticals | 0.5 | $20M | 500k | 40.42 | |
| McDonald's Corporation (MCD) | 0.4 | $20M | 200k | 98.53 | |
| Nektar Therapeutics (NKTR) | 0.4 | $20M | 1.8M | 10.96 | |
| Lendingclub | 0.4 | $20M | 1.5M | 13.23 | |
| Array BioPharma | 0.4 | $18M | 4.0M | 4.56 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $16M | 225k | 70.59 | |
| Crown Castle Intl (CCI) | 0.3 | $16M | 200k | 78.87 | |
| Micron Technology (MU) | 0.3 | $15M | 1.0M | 14.98 | |
| Amazon (AMZN) | 0.3 | $13M | 25k | 511.88 | |
| Time Warner | 0.2 | $10M | 150k | 68.75 | |
| Juno Therapeutics | 0.2 | $9.6M | 235k | 40.69 | |
| iShares MSCI Emerging Markets Indx (EEM) | 0.2 | $8.2M | 250k | 32.78 | |
| Jumei Intl Hldg Ltd Sponsored | 0.1 | $6.4M | 650k | 9.87 | |
| Seres Therapeutics (MCRB) | 0.1 | $5.9M | 200k | 29.64 | |
| Chemocentryx | 0.1 | $5.4M | 900k | 6.05 | |
| Celldex Therapeutics | 0.1 | $4.0M | 375k | 10.54 | |
| BioTime | 0.1 | $3.8M | 1.3M | 3.00 | |
| Ignyta | 0.1 | $4.2M | 475k | 8.78 | |
| Cellectis S A (CLLS) | 0.1 | $3.3M | 125k | 26.36 | |
| Agenus (AGEN) | 0.1 | $2.5M | 550k | 4.60 | |
| Regenxbio Inc equity us cm (RGNX) | 0.1 | $2.6M | 117k | 22.03 | |
| Ironwood Pharmaceuticals (IRWD) | 0.1 | $2.3M | 217k | 10.42 | |
| Hilton Worlwide Hldgs | 0.1 | $2.3M | 100k | 22.94 | |
| Parnell Pharmaceuticals Holdin (PARNF) | 0.0 | $1.7M | 500k | 3.44 | |
| Nantkwest | 0.0 | $2.0M | 175k | 11.46 | |
| Houlihan Lokey Inc cl a (HLI) | 0.0 | $1.6M | 75k | 21.80 | |
| Spectranetics Corporation | 0.0 | $1.2M | 100k | 11.79 | |
| Ceres | 0.0 | $1.1M | 1.0M | 1.08 | |
| XOMA CORP Common equity shares | 0.0 | $300k | 400k | 0.75 | |
| Colucid Pharmaceuticals | 0.0 | $22k | 5.6k | 3.95 |
